Northwestern Mutual Wealth Management’s Vaxcyte PCVX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78.1K	Buy	1,344 +291	+28%	+$15.8K	﹤0.01%	2364
2026 Q1	$61.2K	Buy	1,053 +558	+113%	+$30.3K	﹤0.01%	2369
2025 Q4	$22.8K	Buy	495 +104	+27%	+$4.65K	﹤0.01%	2693
2025 Q3	$14.1K	Buy	391 +127	+48%	+$4.21K	﹤0.01%	2799
2025 Q2	$8.58K	Sell	264 -186	-41%	-$6.1K	﹤0.01%	2846
2025 Q1	$17K	Buy	450 +396	+733%	+$31.7K	﹤0.01%	2575
2024 Q4	$4.42K	Sell	54 -13	-19%	-$1.29K	﹤0.01%	2982
2024 Q3	$7.66K	Buy	+67	New	+$6.04K	﹤0.01%	2777

Other funds holding PCVX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northwestern Mutual Wealth Management's PCVX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Vaxcyte (PCVX) stake by 28% in Q2 2026, buying an estimated $15.8K and bringing the position to 1,344 shares worth $78.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2364.

Northwestern Mutual Wealth Management first reported a position in PCVX in Q3 2024 and has held it in 8 quarters since. 222 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Northwestern Mutual Wealth Management held 1,344 shares of Vaxcyte worth $78.1K as of Q2 2026.
Northwestern Mutual Wealth Management bought 291 Vaxcyte shares in Q2 2026, an estimated $15.8K.
Vaxcyte made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2364 holding.
Northwestern Mutual Wealth Management first reported a position in Vaxcyte in Q3 2024 and has held it in 8 quarters since.
222 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.